PT
ThePornDude
OnlyFans Finder
AI Whores 18+
#1 AI Nude Generator
Sex 'n Dolls
AI Girlfriend
Notícias e Atualizações de Bluejay
Voltar ao PerfilReceba as últimas notícias, atualizações e conteúdo sobre Bluejay. Não perca nenhuma fofoca ou novo conteúdo adulto dela.
Bluejay stock holds value as critical minerals theme strengthens
Within that environment, Bluejay stock sits in a niche between early-stage exploration and potential...
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
ACTON, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE)-- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" o...
Bluejay Sport Review: A Vintage-Looking Ebike For City And Off-Road Adventures
Founded by Jen Cohen Bogan, Bluejay Bikes is a female-owned electric bike brand which made a bit of ...
Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results
Bluejay's first product candidate, an IL-6 Test for sepsis triage, is designed to provide accurate, ...
Bluejay Therapeutics Announces Data Presentations in Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at Upcoming American Association for the Study of Liver Diseases ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Bluejay Therapeutics, a clinical-stage biopharmaceutical company...
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical ...
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds u...
Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care
This Study performs unique rapid on-site measurement using patient whole blood and positions Company...
Mirum beckons Bluejay and its phase 3-stage hepatitis drug for $620M
Mirum Pharmaceuticals is paying $620 million in cash and stock to buy Bluejay Therapeutics and its p...
BlueJay is a music playing, editing, and recording software for Windows
Audio players have come a long way, and these days, many of them are not just about playing tunes an...
Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the ...
REDWOOD CITY, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biop...
This Electric Bike Replaced My Car and Reduced My Carbon Footprint
While each product featured is independently selected by our editors, we may include paid promotion....
Bluejay Mining goes solo at Finland project as JV with Rio Tinto ends
Bluejay Mining (LON: JAY) said Monday that it will take full ownership of the Enonkoski nickel-coppe...
Bluejay Diagnostics Provides Second Quarter Business and Corporate Update
ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" ...
Inside The Growing Popularity of Bluejay e-bikes
The popularity of electric bikes is unmistakable, but Jennifer Cohen Bogan saw a gap in the market f...
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
Company focused on advancing clinical milestones and strategic partnerships, with goal of positionin...
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production
ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" ...
Why Are Traders Watching Bluejay Diagnostics (NASDAQ:BJDX) This Week?
Bluejay Diagnostics (NASDAQ:BJDX) shares climbed after completing enrollment ahead of schedule in it...
Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results
Bluejay's Symphony System (the "Symphony System") is designed to address the need for simple, reliab...
Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and ...
SYMON-II pivotal clinical study completes targeted enrollment of 750 patients Company advances towar...
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay"...
Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal'
・Brelovitug is a late-stage experimental drug being studied for chronic hepatitis delta virus infe...
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
ACTON, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" ...
Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patie...
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
ACTON, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay...
Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
SAN MATEO, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a private biopharmaceutic...
23-year-old cofounders left Amazon and Microsoft to build an AI startup. Read their Y Combinator pitch deck.
Bluejay's cofounders left their jobs at Amazon and Microsoft and raised $4 million to build an AI ag...
Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test
ACTON, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay",...
Bluejay Diagnostics announces 1-for-4 reverse stock split
Bluejay Diagnostics (BJDX) on Tuesday announced a 1-for-4 reverse stock split, effective 12:01 AM ET...
23-year-old engineers quit Amazon and Microsoft to build an AI startup in a 'hacker house,' inspired by a bird, and secure $4 million seed funding
Rohan Vasishth and Faraz Siddiqi, both 23, quit their early-career jobs at Amazon and Microsoft earl...